Routine Diagnostic Test

Vial has entered a partnership with Nielsen BioSciences Inc. to support Nielsen’s phase 3 trial of Candin for the treatment of verruca vulgaris, according to a company press release.

LAS VEGAS — Certain red flags can indicate that a patient’s headaches are the migraine type, Merle Diamond, MD, said at PAINWeek 2022.

Quanterix Corp. announced the validation of a laboratory-developed test to quantitatively measure phospho-Tau 181 concentration in plasma to aid in the diagnosis of Alzheimer’s disease.

Most of the emergency use authorizations the FDA issued related to COVID-19 were “not supported by high-quality evidence,” the authors of a cross-sectional study wrote in JAMA Internal Medicine.

Nearly half of the world’s population, primarily in low- and middle-income countries, has little to no access to essential diagnostic tools for common diseases, according to findings published by The Lancet Commission on Diagnostics.

The U.S. Preventive Services Task Force issued updated recommendations for colorectal cancer screening in JAMA.

Providers in the primary care setting often overestimate the probability of a diagnosis before and after testing, suggesting that many are “unaccustomed to using probability in diagnosis and clinical practice,” researchers said.

SAN FRANCISCO — Researchers compared current whole genome sequencing methods with a new PCR diagnostic test and found that the new test provided quicker results, allowing testing during an outbreak to begin immediately, according to data presented at ASM Microbe.